The Role of Glutamate and Blood–Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression
Cells · 21.07.2024 · 13 (14) · 1228
DOI: 10.3390/cells13141228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 21.07.2024. Verfasst von Benjamin F Gruenbaum und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Glutamic Acid, Epilepsy, Depression. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Epilepsy is associated with substantial neuropsychiatric impairments that persist long after the onset of the condition, significantly impacting quality of life. The goal of this review was to uncover how the pathological consequences of epilepsy, such as excessive glutamate release and a disrupted blood–brain barrier (BBB), contribute to the emergence of neuropsychiatric disorders. We hypothesize that epilepsy induces a dysfunctional BBB through hyperexcitation, which then further amplifies post-ictal glutamate levels and, thus, triggers neurodegenerative and neuropsychiatric processes. This review identifies the determinants of glutamate concentration levels in the brain and explores potential therapeutic interventions that restore BBB integrity. Our focus on therapeutic BBB restoration is guided by the premise that it may improve glutamate regulation, consequently mitigating the neurotoxicity that contributes to the onset of neuropsychiatric symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.
- New York Medical College, Valhalla, NY 10595, USA.
- Department of Anesthesiology and Critical Care, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel.
ORCID-Profile: Benjamin F Gruenbaum, Matthew Boyko
Zitieren
APA
Gruenbaum, B. F., Schonwald, A., Boyko, M., & Zlotnik, A. (2024). The Role of Glutamate and Blood–Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression. Cells, 13(14), 1228. https://doi.org/10.3390/cells13141228
Vancouver
Gruenbaum BF, Schonwald A, Boyko M, Zlotnik A. The Role of Glutamate and Blood–Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression. Cells. 2024;13(14):1228. doi:10.3390/cells13141228
BibTeX
@article{Gruenbaum2024,
author = {Gruenbaum, Benjamin F and Schonwald, Antonia and Boyko, Matthew and Zlotnik, Alexander},
title = {The Role of Glutamate and Blood–Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression},
journal = {Cells},
year = {2024},
volume = {13},
number = {14},
pages = {1228},
doi = {10.3390/cells13141228}
}
EUVIMED